survodutide vs retatrutide is one of the “next-gen” incretin-style drugs that has a “stacked mechanism”. Instead of being a single-pathway GLP-1RA like semaglutide, it's a dual agonist hitting both the GLP-1 receptor and the CagriSema vs Retatrutide 2026: Approval
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20





















:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)





